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Abstract
Background:  Previous studies of maternal risk factors for abnormal placental growth have
focused on placental weight and placental ratio as measures of placental growth. We sought to
identify maternal risk factors for placental weight and two neglected dimensions of placental
growth: placental thickness and chorionic plate area.
Methods: We conducted an analysis of 24,135 mother-placenta pairs enrolled in the National
Collaborative Perinatal Project, a prospective cohort study of pregnancy and child health. We
defined growth restriction as < 10th percentile and hypertrophy as > 90th percentile for three
placental growth dimensions: placental weight, placental thickness and chorionic plate area. We
constructed parallel multinomial logistic regression analyses to identify (a) predictors of restricted
growth (vs. normal) and (b) predictors of hypertrophic growth (vs. normal).
Results: Black race was associated with an increased likelihood of growth restriction for placental
weight, thickness and chorionic plate area, but was associated with a reduced likelihood of
hypertrophy for these three placental growth dimensions. We observed an increased likelihood of
growth restriction for placental weight and chorionic plate area among mothers with hypertensive
disease at 24 weeks or beyond. Anemia was associated with a reduced likelihood of growth
restriction for placental weight and chorionic plate area. Pre-pregnancy BMI and pregnancy weight
gain were associated with a reduced likelihood of growth restriction and an increased likelihood of
hypertrophy for all three dimensions of placental growth.
Conclusion: Maternal risk factors are either associated with placental growth restriction or
placental hypertrophy not both. Our findings suggest that the placenta may have compensatory
responses to certain maternal risk factors suggesting different underlying biological mechanisms.
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Background
Placental structure and function determine the growth tra-
jectory of the fetus. Several studies show that abnormal
placental growth is associated with adverse pregnancy
outcomes [1-3]. A disproportionately heavy placenta, sug-
gestive of placental hypertrophy, may indicate an adaptive
response to an adverse intrauterine environment. Placen-
tal hypertrophy may occur in the presence of conditions
such as maternal anemia [4], cigarette smoking [5] and
lower socio-economic status [6]. Conversely, a dispropor-
tionately small placenta may indicate poor nutrient sup-
ply to the placenta, or hypoxia resulting in placental
growth restriction and subsequently fetal growth restric-
tion [3].
Effects of individual maternal risk factors on placental
weight and its ratio to birth weight have been previously
studied [5-12]. Placental weight, however, is a gross sum-
mary measure, devoid of biologic and mechanistic detail.
Multi-dimensional measures of placental growth may
provide further insight into the understanding of underly-
ing mechanisms of fetal adaptation and the gestational
intervals in which these processes occur. For example, lat-
eral growth of the chorionic plate plateaus in the middle
of the third trimester, while thickness of the placenta
increases primarily between 30 and 32 weeks gestation
[9].
We are not aware of prior studies identifying maternal risk
factors for abnormal placental growth where placental
growth is assessed using multidimensional measures of
growth. We examined three dimensions of placental
growth: 1) placental weight; 2) placental thickness; and 3)
chorionic plate area, using data from the National Collab-
orative Perinatal Project (NCPP). The NCPP is a unique
US population-based birth cohort that includes maternal
sociodemographic, clinical and obstetric data, gross pla-
cental measures and histopathology, infant birth charac-
teristics and childhood growth measures up to age 8. This
data provides an excellent opportunity to estimate the
influence of maternal characteristics on three dimensions
of placental growth in a large population-based sample.
Therefore, our objectives were to 1) determine whether
maternal characteristics were associated with multidimen-
sional measures of placental growth and if so, 2) estimate
the magnitude of association of maternal factors with pla-
cental growth restriction (< 10th percentile in placental
weight, thickness or chorionic plate area; and placental
hypertrophy (> 90th percentile for placental weight, thick-
ness or chorionic plate area. We hypothesized that lower
socioeconomic status (e.g. annual household income,
education) would be associated with increased likelihood
of placental growth restriction. We also hypothesized that
hypertensive disease would be associated with an
increased likelihood of placental growth restriction and
anemia and gestational diabetes would be associated with
increased likelihood of placental hypertrophy.
Methods
Study Population
The Collaborative Perinatal Project was a prospective
cohort study of pregnancy and child health enrolling par-
ticipants between 1959–1966. It was specifically designed
to identify determinants of cerebral palsy and allied neu-
rological defects [13]. A detailed description of the meth-
ods is published elsewhere [13]. Briefly, approximately
42,000 pregnant women were enrolled at 12 hospitals
across the United States (Baltimore MD, Boston MA, Buf-
falo NY, Memphis TN, Minneapolis MN, New Orleans LA,
New York NY [2 hospitals], Philadelphia PA, Portland
OR, Providence RI and Richmond VA). Pregnant women
were usually enrolled at their first prenatal visit. Partici-
pants were deemed ineligible if they were incarcerated,
were planning to move from the area, planned to give the
child up for adoption or gave birth on the day they were
recruited into the study. Records were not kept for women
who refused participation at baseline.
Selection Criteria
For the present analysis, eligible mothers met the follow-
ing criteria: 1) either Black or Caucasian 2) gave birth to
live-born singletons, 3) no congenital anomaly, and 4)
gestational age ≥ 36 and ≤ 42 weeks.
Data Collection
Maternal sociodemographic characteristics (age, educa-
tion, annual household income, smoking status, race)
and parity were obtained by self-report during a personal
interview. Maternal age was based on age at entry into the
study. Education was based on the number of years of
education attained and we categorized mothers as having
< 12 years vs. 12 or more years of education. Annual
household income was collected using categories of
$1000 and we dichotomized annual household income
using < $5000 vs. $5000 or more (equivalent to $30,000
in 2005). Mothers were classified as non-smokers, light
smokers (< 1 pack per day) or heavy smokers (≥ 1 pack per
day) at the time of the interview. Obstetrical factors were
obtained from clinical examination and laboratory test-
ing. Anemia was defined as having hemoglobin < 10.0 g/
dL or hematocrit [Hct] < 30% at any time point during the
pregnancy. Mothers were classified as having gestational
diabetes if they were diagnosed with diabetes, initiated
insulin, received an abnormal glucose tolerance test
result, or had a blood glucose ≥ 200 mg/dL during the
pregnancy. Hypertensive disease was defined as having a
systolic blood pressure ≥ 160 mmHg or a diastolic blood
pressure  ≥ 90 mmHg and thus includes women withBMC Pregnancy and Childbirth 2008, 8:44 http://www.biomedcentral.com/1471-2393/8/44
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chronic hypertension, pregnancy-induced hypertension
and preeclampsia.
Maternal weight and height were measured upon enroll-
ment in the study and mother's weight prior to pregnancy
was based on self report. Maternal pre-pregnancy body-
mass index (BMI) was calculated as pre-pregnancy weight
in kilograms divided by measured height in meters
squared. At delivery, just prior to giving birth, mother's
weight was measured to determine pregnancy weight
gain.
Placental Measurements
Placentas were collected at delivery and examined by
trained pathologists according to a standard protocol
[14]. Briefly, the length of the umbilical cord was meas-
ured and examined for knots and areas of marked edema.
The distance from the base of the cord to the closest pla-
cental margin (cord insertion distance) was also measured
then the cord was severed at the point of insertion. The
largest and smallest diameters were recorded in centime-
ters and the thickness was measured at the center of the
placental tissue by piercing it with a sharp rod calibrated
in millimeters. The membranes were then trimmed near
the margin of insertion. After removal of the membranes,
cord, and any blood clots, the placenta was weighed. We
estimated chorionic plate area using the formula for the
area [A] of an ellipse
where dL is the largest diameter and dS is the smallest
diameter.
Outcome Measures
Our primary outcomes are the three dimensions of pla-
cental growth: placental weight, thickness and chorionic
plate area. For each of the three dimensions of placental
growth studied–placental weight, placental thickness, and
chorionic plate area–the growth dimension was classified
as 'restricted' if it was < 10th percentile and 'hypertrophic'
if > 90th percentile. Growth dimensions that fell within
the 10th to 90th percentile were considered 'normal'. We
used the distribution of the placental measures in the
NCPP sample to derive the percentiles used in the classifi-
cation of restriction and hypertrophy.
Statistical Analysis
Descriptive statistics, frequencies for categorical variables
and means and standard deviations for continuous varia-
bles were calculated. For each of the three placental
growth parameters (weight, thickness, and area), we con-
structed parallel multinomial logistic regression analyses
to identify (a) predictors of restricted growth (vs. normal)
and (b) predictors of hypertrophic growth (vs. normal).
In multivariate models, we included maternal age,
income, education, race, smoking status, pre-pregnancy
BMI, pregnancy weight gain, parity, anemia, gestational
diabetes and hypertensive disease as covariates. Results
were robust before and after adjustment, therefore we
present only adjusted odds ratios in the tables. Analyses
were conducted using STATA statistical software (version
9.0; Stata Corporation, College Station, Texas). We pro-
vided 95% confidence intervals for all estimates. We used
a 2-sided Bonferroni-adjusted P value of (0.0045) to test
for significance in multivariate models because of the pos-
sibility that some associations with the 11 risk factors
might have arisen due to chance. The study was approved
by the Johns Hopkins Medicine Institutional Review
Board.
Results
Four percent of the subjects enrolled were lost to follow
up before delivery. Of 34,345 eligible mothers, 10,921
were excluded from analysis because of missing values for
variables of interest. An additional 4 were excluded due to
implausible values, leaving an analytic sample of 23,420
mothers. Compared to the participants excluded from the
analysis, participants in the analytic sample were slightly
older, more likely to be White, and more likely to have
annual household income greater than $5000 (equivalent
to $30,000 in 2005; all P < 0.05).
Table 1 summarizes characteristics of 23,420 mothers.
The mean age of mothers was 24.5 years. Almost half of
the mothers were Black and about half did not complete
high school. The majority of the mothers had an annual
household income less than $5000, equivalent to less
than $30,000 in 2005. Almost half of the women were
current smokers. By present standards, the women were
fairly lean with a mean pre-pregnancy body mass index
[BMI] of 22.8 kg/m2. The mean weight gain during preg-
nancy was 9.7 kg, less than the 11–15 kg recommended
today for normal weight women. Most of the women
(71.5%) had a previous live birth. Anemia was common
(21.5%), but gestational diabetes was not (1.6%). About
2% of the women had hypertensive disease.
The results of the multinomial logistic regression analysis
for placental growth restriction are shown in Table 2.
Compared to their counterparts, black women were more
likely to have evidence of growth restriction for all three
placental growth dimensions examined with relative risk
ratios [RRR] ranging from 1.36 to 3.22. Compared to their
healthier counterparts, mothers with hypertensive disease
were almost twice as likely to produce placentas that were
growth-restricted for placental weight and chorionic plate
area with RRRs of 1.98; 95% Confidence Interval [CI]
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contrast, mothers with less than 12 years of education
compared to mothers with at least 12 years of education
were approximately 20% less likely to have evidence of
growth restriction for all three dimensions of growth. Sim-
ilarly, mothers with an annual household income less
than $5000 compared to those with income greater than
$5000, were 20% less likely to have evidence of growth
restriction for placental thickness. Pre-pregnancy BMI,
and pregnancy weight gain both appeared to be protec-
tive, showing inverse associations with growth restriction
for all three dimensions of placental growth. In addition,
mothers with anemia were 33% and 20% less likely to
have growth restriction for placental weight and chorionic
plate area respectively.
Predictors of hypertrophy for all three placental growth
dimensions included pre-pregnancy BMI, and pregnancy
weight gain. For every unit increase in pre-pregnancy BMI
there was a 4 to 10% increase in the likelihood of placen-
tal hypertrophy. Similarly, for every kg increase in preg-
nancy weight gain, there was a 3 to 7% increase in the
likelihood of placental hypertrophy. Mothers with an
annual household income less than $5000 were 19% and
20% more likely to have hypertrophy compared to moth-
ers with incomes $5000 or more for placental weight and
chorionic plate area respectively. Mothers with anemia
were 50% and 45% more likely to have hypertrophy com-
pared to mothers without anemia for placental weight
and chorionic plate area respectively. Compared to nul-
liparous women, parous women were 25% and 32%
more likely to have hypertrophic growth for placental
weight and thickness respectively. Mothers with gesta-
tional diabetes were 75% and 59% more likely to have
hypertrophic growth for placental weight and chorionic
plate area respectively. In contrast, after accounting for
other sociodemographic factors, black mothers were 20%
to 43% less likely than their white counterparts to have
hypertrophy of all three dimensions of placental growth.
Discussion
Most maternal risk factors were associated with either a
hypertrophic or restrictive adaptive growth response of
the placenta. Black race was associated with an increased
likelihood of growth restriction for placental weight,
thickness and chorionic plate area, but was associated
with a reduced likelihood of hypertrophy for these three
placental growth dimensions. We only observed an
increased likelihood of growth restriction for weight and
chorionic plate area among mothers with hypertensive
disease. Conversely, anemia was associated with a
reduced likelihood of growth restriction for placental
weight and chorionic plate area. Pre-pregnancy BMI and
pregnancy weight gain were associated with a reduced
likelihood of growth restriction and an increased likeli-
hood of hypertrophy for all three dimensions of placental
growth examined.
The relationship between Black race and placental growth
is similar to that observed with birth weight. Blacks are
more likely to deliver low birth weight infants compared
to their White counterparts [15,16] and in our study
Blacks have a higher likelihood of restriction for placental
weight, thickness and chorionic plate area. Placental
growth precedes birth weight, and previous studies show
a positive relationship between placental weight and birth
weight [17]. Therefore one could propose that the rela-
tionship between Black race and birth weight may be
mediated by placentation and placental function. Further
understanding of the relationship between placental
growth and factors influencing placental growth may elu-
cidate understanding of the cause of race disparity with
respect to birth weight and other birth outcomes.
In our study, after adjustment for confounding factors, we
observed an increased likelihood of placental hypertro-
phy and a decreased likelihood of placental growth
restriction based on placental weight and chorionic plate
Table 1: Selected Characteristics of 23,420 Mother Placenta 
Pairs in the Collaborative Perinatal Project.
Maternal Socio-Demographic Characteristics
Age (years) 24.5 ± 5.9
Education (years)
≥ 12 11,087 (47.4)





≥ $5,000† 6,907 (29.5)
< $5,000† 16,513 (70.5)
Smoking Intensity 22.8 ± 4.3
Non-Smoker 12, 350 (52.7)
Light Smoker (< 1 pack/day) 7, 084 (30.3)
Heavy Smoker (≥ 1 pack/day) 3, 986 (17.0)
Pre-pregnancy BMI (kg/m2) 22.8 ± 4.3
Pregnancy weight gain (kg) 9.7 ± 5.0
Maternal Obstetric Characteristics
Anemia 5,024 (21.5)
Gestational Diabetes 360 (1.6)





Placental Weight (grams) 438 ± 92
Placental thickness (mm) 21.9 ± 4.8
Chorionic plate area (cm2) 247.5 ± 51.3
All results presented as n (%) or mean ± SD
† Equivalent to approximately $30,000 in 2005.BMC Pregnancy and Childbirth 2008, 8:44 http://www.biomedcentral.com/1471-2393/8/44
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area in the presence of anemia. However, our findings
should be interpreted with caution since we were unable
to separate anemia resulting from maternal under-nutri-
tion or chronic disease versus pregnancy-related physio-
logic anemia. The literature on the relationships between
maternal anemia and placental weight, and its ratio to
birth weight are inconsistent. On the one hand, placental
weight and placental ratio appear to increase with severe
maternal anemia and this effect has been attributed to
maternal under nutrition [7,12,18-20]. The thought is
that fetal hypoxemia develops consequent to anemia and
stimulates growth in order to increase surface area of dif-
fusion exchange and thus offset the impaired oxygen
transport [5]. However, there is conflicting evidence
showing that placental ratio is lower in the presence of
severe iron deficiency anemia [20]. Based on our study
results, we are unable to make conclusive statements in
support either relationship.
In our study we found that gestational diabetes was asso-
ciated with an increased risk of placental hypertrophy
based on placental weight and chorionic plate area. When
we examined the distribution of placental growth meas-
ures by gestational diabetes status, we observed an
upward shift in the distribution for the subpopulation
with gestational diabetes. One explanation for this find-
ing is the increase in the proliferation of peripheral villi
and an increase in the length of villi and capillaries
observed in the presence of gestational diabetes. This may
compensate for the reduced perfusion due the increased
vascular resistance [21].
Our study has several strengths. First, to our knowledge,
this is the first epidemiologic study to examine the associ-
ation between maternal risk factors and abnormal placen-
tal growth defined using chorionic plate area and
placental thickness in addition to placental weight. Sec-
ond, we were able to assess the relationship between
maternal characteristics and placental growth in a popula-
tion-based sample where the placentas were examined
using standardized protocol. Finally, the sample size was
large providing great statistical precision.
Several limitations of our study deserve comment. The
NCPP is a historical dataset from the 1950's and the man-
agement of high-risk obstetrical complications has
Table 2: Multivariate Regression Coefficients for the Association of Maternal Risk Factors with Placental Weight, Thickness and 




















Maternal age (per 5 years) 1.00 (0.99, 1.01) 1.02* (1.01, 1.03) 0.99* (0.98, 0.99) 1.01 (1.00, 1.02) 0.99 (0.98, 1.00) 1.04* (1.03, 1.05)
AnnualFamily Income
< $5,000 vs ≥ $5,000 0.88 (0.80, 0.98) 0.79* (0.71, 0.89) 0.87 (0.79, 0.96) 1.19* (1.08, 1.32) 0.92 (0.83, 1.02) 1.21* (1.07, 1.34)
Maternal Education
< 12 yrs vs ≥ 12 yrs 0.83* (0.76, 0.91) 0.78* (0.71, 0.86) 0.87* (0.80, 0.95) 1.09 (0.99, 1.19) 1.15 (1.04, 1.26) 0.94 (0.85, 1.04)
Maternal Race
Black vs White 1.66* (1.51, 1.82) 3.22* (2.90, 3.58) 1.36* (1.24, 1.49) 0.57* (0.51, 0.63) 0.70* (0.64, 0.77) 0.80* (0.72, 0.89)
Smoking Status
Light vs Non-smoker 0.92 (0.84, 1.02) 1.03 (0.93, 1.13) 0.94 (0.86, 1.03) 0.95 (0.85, 1.05) 0.89 (0.81, 0.99) 1.09 (0.98, 1.21)
Heavy vs Non-smoker 1.00 (0.89, 1.13) 1.11 (0.98, 1.27) 0.92 (0.82, 1.03) 0.96 (0.85, 1.09) 0.85 (0.75, 0.97) 1.12 (0.98, 1.27)
Parity
Parous vs Nulliparous 0.89 (0.80, 0.98) 0.98 (0.88, 1.10) 1.06 (0.96, 1.17) 1.25* (1.11, 1.40) 1.32* (1.18, 1.48) 1.09 (0.96, 1.23)
Anemia
Yes vs No 0.67* (0.60, 0.74) 1.00 (0.91, 1.56) 0.80* (0.72, 0.89) 1.50* (1.34, 1.67) 1.18 (1.05, 1.32) 1.45* (1.30, 1.63)
Gestational Diabetes
Yes vs No 0.77 (0.51, 1.16) 0.77 (0.51, 1.18) 0.68 (0.45, 1.02) 1.75* (1.33, 2.32) 1.29 (0.94, 1.76) 1.59* (1.18, 2.13)
Hypertensive Disease
Yes vs No 1.98* (1.54, 2.55) 1.19 (0.91, 1.56) 1.86* (1.46, 2.37) 0.62* (0.46, 0.84) 0.69 (0.50, 0.95) 0.89 (0.66, 1.19)
Pre-pregnancy BMI (per 1 
kg/m2)
0.91* (0.90, 0.92) 0.98* (0.97, 0.99) 0.93* (0.92, 0.95) 1.10* (1.06, 1.08) 1.05* (1.04, 1.06) 1.04* (1.03, 1.05)
Pregnancy Weight Gain 
(per 1 kg)
0.93* (0.92, 0.94) 0.99 (0.98, 1.00) 0.96* (0.95, 0.97) 1.07* (1.06, 1.08) 1.03* (1.02, 1.04) 1.05* (1.04, 1.06)
*P < 0.0045 (Bonferroni-adjusted p-value applied for significance testing)
All results presented as Regression co-efficient (95% Confidence Interval)BMC Pregnancy and Childbirth 2008, 8:44 http://www.biomedcentral.com/1471-2393/8/44
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changed substantially over time and cannot be fully
adjusted for in multivariate models. However the NCPP
represents a large US population-based database that
includes maternal variables and detailed placental meas-
urements. Participants excluded from the analysis differed
significantly from those included, which introduces some
bias. Given the large sample size we suspect this bias is
small. Since all women were not routinely screened for
GDM during the study time frame, we have likely under-
estimated the prevalence of GDM in the study sample. We
anticipate that an underestimate of GDM prevalence
might have limited the power to detect statistically signif-
icant associations between GDM and placental growth.
Furthermore, the criterion used to define GDM has
changed over time which may also have contributed to
the low prevalence of GDM observed. Mother's pre-preg-
nancy weight was obtained by self-report. Although self
reported and measured weights tend to be highly corre-
lated [22-25], accuracy may vary significantly according to
age and socioeconomic status [23]. In general women
tend to underestimate their weight. There was measure-
ment error in the assessment of the placental growth
measures. Placental thickness was assessed only at the
center of the placenta. There is some variation of placental
thickness throughout the placental organ and since thick-
ness represents diffusion conductance, perhaps it would
be more representative if thickness was measured at differ-
ent sites and then a mean thickness calculated. There may
be some differential validity in the measurement of largest
and smallest diameter with regard to placental shape used
in the estimation of chorionic plate area. In addition, our
estimate of chorionic plate area assumes that the placenta
is shaped as an ellipse; therefore we expect that there may
be a slight overestimation.
Finally, we are unable to generalize our results to the gen-
eral population of today since the sample was enrolled
over 40 years ago and was comprised largely of low
income African American women. The incidence of
maternal risk factors has changed over time. The mothers
were leaner and gained less weight during pregnancy than
would be expected in a more contemporary cohort.
Conclusion
Our study results suggest that adverse obstetric conditions
are either associated with placental growth restriction or
placental hypertrophy, but not both. This implies that the
placenta may have specific compensatory responses to
adverse maternal obstetric conditions, each with a distinct
pathophysiologic mechanism. Further research in a con-
temporary cohort is warranted to elucidate the biological
mechanisms underlying the associations between anemia,
gestational diabetes, hypertensive disease, maternal pre-
pregnancy BMI, and pregnancy weight gain with abnor-
mal placental growth and to determine whether abnormal
placental growth might mediate effect on birth weight and
childhood growth.
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